N. V. Lyubimova

589 total citations
49 papers, 419 citations indexed

About

N. V. Lyubimova is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N. V. Lyubimova has authored 49 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N. V. Lyubimova's work include Neuroendocrine Tumor Research Advances (10 papers), Bone health and treatments (9 papers) and Lung Cancer Research Studies (9 papers). N. V. Lyubimova is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), Bone health and treatments (9 papers) and Lung Cancer Research Studies (9 papers). N. V. Lyubimova collaborates with scholars based in Russia, United Kingdom and United States. N. V. Lyubimova's co-authors include J. W. Hopewell, Н. Е. Кушлинский, Roger F. Martin, Paul A. Cloos, Per Qvist, Stephan Christgau, Marianna Selikhova, Е. И. Гусев, I. Byrjalsen and Helene Solberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Breast Cancer Research and British Journal of Radiology.

In The Last Decade

N. V. Lyubimova

37 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. V. Lyubimova Russia 11 158 121 106 106 63 49 419
Zhenxiong Wang China 11 181 1.1× 235 1.9× 195 1.8× 113 1.1× 24 0.4× 24 551
Steven Schoenfeld United States 10 121 0.8× 129 1.1× 38 0.4× 41 0.4× 156 2.5× 13 478
Angela Coliva Italy 13 206 1.3× 90 0.7× 73 0.7× 193 1.8× 30 0.5× 28 474
Cynthia T. Welsh United States 11 47 0.3× 101 0.8× 153 1.4× 116 1.1× 93 1.5× 33 537
Bram Maas Netherlands 9 109 0.7× 91 0.8× 193 1.8× 349 3.3× 94 1.5× 12 578
Róisín Armstrong United Kingdom 4 171 1.1× 146 1.2× 32 0.3× 23 0.2× 20 0.3× 12 894
Hanna Yoo South Korea 14 35 0.2× 211 1.7× 41 0.4× 32 0.3× 14 0.2× 33 458
C.J.M. Lips Netherlands 18 275 1.7× 372 3.1× 53 0.5× 93 0.9× 23 0.4× 37 1.2k
Mart A. A. M. Heesters Netherlands 8 97 0.6× 104 0.9× 98 0.9× 186 1.8× 235 3.7× 10 472
Debbie Saunders United States 6 69 0.4× 76 0.6× 91 0.9× 63 0.6× 62 1.0× 7 323

Countries citing papers authored by N. V. Lyubimova

Since Specialization
Citations

This map shows the geographic impact of N. V. Lyubimova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. V. Lyubimova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. V. Lyubimova more than expected).

Fields of papers citing papers by N. V. Lyubimova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. V. Lyubimova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. V. Lyubimova. The network helps show where N. V. Lyubimova may publish in the future.

Co-authorship network of co-authors of N. V. Lyubimova

This figure shows the co-authorship network connecting the top 25 collaborators of N. V. Lyubimova. A scholar is included among the top collaborators of N. V. Lyubimova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. V. Lyubimova. N. V. Lyubimova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lyubimova, N. V., et al.. (2022). Assessment of iron metabolism disorders and adequate treatment of anemic syndrome in patients with breast cancer on the background of adjuvant chemotherapy. Russian Clinical Laboratory Diagnostics. 67(4). 213–218. 1 indexed citations
2.
Lyubimova, N. V., et al.. (2022). Peculiarities of iron metabolism in patients with breast cancer before adjuvant chemotherapy. Russian Journal of Biotherapy. 21(1). 33–41.
3.
4.
Lyubimova, N. V., et al.. (2021). DIAGNOSTICS AND TREATMENT OF ANEMIC SYNDROME IN PATIENTS WITH BREAST CANCER ON THE BACKGROUND OF NEOADJUVANT CHEMOTHERAPY. Russian Journal of Biotherapy. 20(2). 42–52.
5.
Lyubimova, N. V., et al.. (2020). Inhibin B in stromal-cell ovarian tumors. SHILAP Revista de lepidopterología. 7(1). 32–37.
6.
Lyubimova, N. V., et al.. (2020). Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Malignant Glial Tumors. Bulletin of Experimental Biology and Medicine. 168(4). 503–506. 8 indexed citations
7.
Lyubimova, N. V., et al.. (2018). DIFFUSION-WEIGHTED IMAGING WITH ADC-MAPS IN ASSESSEMENT OF LIVER TRANSARTERIAL CHEMOEMBOLIZATION RESPONSE IN PATIENTS WITH METASTATIC NEUROENDOCRINE TUMORS. Russian Electronic Journal of Radiology. 8(4). 103–110. 1 indexed citations
8.
Lyubimova, N. V., et al.. (2017). Free Immunoglobulin Light Chains as Criteria of Extracorporeal Hemocorrection in Patients with Monoclonal Gammopathies. Bulletin of Experimental Biology and Medicine. 163(4). 493–496. 2 indexed citations
9.
Lyubimova, N. V., et al.. (2016). Chromogranin As a Biochemical Marker of Neuroendocrine Tumors. Bulletin of Experimental Biology and Medicine. 160(5). 702–704. 16 indexed citations
10.
Lyubimova, N. V., et al.. (2015). Biochemical markers of bone metastasis. SHILAP Revista de lepidopterología. 2(1). 61–75. 6 indexed citations
11.
Lyubimova, N. V., et al.. (2014). Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Lyubimova, N. V., et al.. (2014). Use of inhibin B in recurrent ovarian granulosa cell tumors. SHILAP Revista de lepidopterología.
13.
Кушлинский, Н. Е., et al.. (2014). Components of the RANK/RANKL/OPG System, IL-6, IL-8, IL-16, MMP-2, and Calcitonin in the Sera of Patients with Bone Tumors. Bulletin of Experimental Biology and Medicine. 157(4). 520–523. 20 indexed citations
14.
Lyubimova, N. V., et al.. (2011). Granulosa Cell Tumors of the Ovary and Inhibin B. Bulletin of Experimental Biology and Medicine. 150(5). 635–638. 7 indexed citations
15.
Lyubimova, N. V. & J. W. Hopewell. (2004). Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury. British Journal of Radiology. 77(918). 488–492. 102 indexed citations
16.
Lyubimova, N. V., et al.. (2004). Tartrate-Resistant Acid Phosphatase as a Marker of Bone Metastases in Patients with Breast Cancer and Prostate Cancer. Bulletin of Experimental Biology and Medicine. 138(1). 77–79. 30 indexed citations
17.
Lyubimova, N. V., et al.. (2003). Analysis of Elastase 1 for Evaluation of Excretory Function of the Pancreas after Gastropancreatoduodenal Resection. Bulletin of Experimental Biology and Medicine. 135(1). 34–36. 4 indexed citations
18.
Cloos, Paul A., Stephan Christgau, N. V. Lyubimova, et al.. (2003). Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments. Breast Cancer Research. 5(4). R103–9. 18 indexed citations
19.
Lyubimova, N. V., et al.. (2002). Diagnostic Value of Tumor Markers Cyfra 21-1 and Neuron-Specific Enolase in Analysis of Pleural Fluid. Bulletin of Experimental Biology and Medicine. 133(5). 478–480. 3 indexed citations
20.
Lyubimova, N. V., et al.. (2001). In vivoradioprotection of mouse brain endothelial cells by Hoechst 33342. British Journal of Radiology. 74(877). 77–82. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenxiong Wang Breakdown of academic impact, for papers by Steven Schoenfeld Breakdown of academic impact, for papers by Angela Coliva Breakdown of academic impact, for papers by Cynthia T. Welsh Breakdown of academic impact, for papers by Bram Maas Breakdown of academic impact, for papers by Róisín Armstrong Breakdown of academic impact, for papers by Hanna Yoo Breakdown of academic impact, for papers by C.J.M. Lips Breakdown of academic impact, for papers by Mart A. A. M. Heesters Breakdown of academic impact, for papers by Debbie Saunders
Rankless by CCL
2026